Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Mantle-Cell × tocilizumab × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 5 Recurrence 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Carcinoma, Non-Small-Cell Lung 2 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 Lymphoma, Mantle-Cell 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Cytokine Release Syndrome 1 Craniopharyngioma 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Advanced Liver Cancers 1

Interventions

Rituximab 21 zanubrutinib 11 Cyclophosphamide 10 pirtobrutinib 8 fludarabine 8 acalabrutinib 8 Magnetic Resonance Spectroscopy 8 Bendamustine Hydrochloride 8 obinutuzumab 7 Specimen Handling 7 venetoclax 6 glofitamab 6 Biopsy 6 orelabrutinib 5 Cytarabine 5 ibrutinib 4 fludarabine phosphate 4 Lenalidomide 4 CT-P10 3 tafasitamab 2 loncastuximab tesirine 2 brexucabtagene autoleucel 2 Whole-Body Irradiation 2 Prednisone 2 Maintenance 2 Doxorubicin 2 Cyclosporine 2 Automobiles 2 treosulfan 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05833763 2024-01-08

GOlDiLOX

Australasian Leukaemia and Lymphoma Group

Phase 2 Recruiting

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡